Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 19, 2018 - Issue 7
Submit an article Journal homepage
193
Views
1
CrossRef citations to date
0
Altmetric
Drug Evaluation

Intravenous carbamazepine for the treatment of epilepsy

Francesco BrigoDepartment of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona, Italy;Department of Neurology, Franz Tappeiner Hospital, Merano, ItalyORCID Iconhttp://orcid.org/0000-0003-0928-1577View further author information
ORCID Icon,
Antonio LeoDepartment of Science of Health, School of Medicine, University of Catanzaro, Catanzaro, ItalyORCID Iconhttp://orcid.org/0000-0002-0061-1608View further author information
ORCID Icon,
Emilio RussoDepartment of Science of Health, School of Medicine, University of Catanzaro, Catanzaro, ItalyORCID Iconhttp://orcid.org/0000-0002-1279-8123View further author information
ORCID Icon,
Pasquale StrianoPediatric Neurology and Muscular Diseases Unit, DINOGMI-Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health University of Genoa, ‘G. Gaslini’ Institute, Genova, ItalyORCID Iconhttp://orcid.org/0000-0002-6065-1476View further author information
ORCID Icon &
Vincenzo BelcastroNeurology Unit, S. Anna Hospital, Como, ItalyCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-3416-2900View further author information
ORCID Icon
Pages 743-747 | Received 20 Feb 2018, Accepted 04 Apr 2018, Published online: 12 Apr 2018

References

  • Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55:475–482.
  • Banerjee PN, Filippi D, Allen Hauser W. The descriptive epidemiology of epilepsy – a review. Epilepsy Res. 2009;85:31–45.
  • Kwan P, Brodie MJ. Early identification of refractory epilepsy. N Engl J Med. 2000;342:314–319.
  • Glauser T, Ben-Menachem E, Bourgeois B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013;54:551–563.
  • Wang SP, Mintzer S, Skidmore CT, et al. Seizure recurrence and remission after switching antiepileptic drugs. Epilepsia. 2013;54:187–193.
  • Finamore JM, Sperling MR, Zhan T, et al. Seizure outcome after switching antiepileptic drugs: a matched, prospective study. Epilepsia. 2016;57:1294–1300.
  • Neuvonen PJ, Tokola O. Bioavailability of rectally administered carbamazepine mixture. Br J Clin Pharmacol. 1987;24:839–841.
  • Graves NM, Kriel RL, Jones-Saete C, et al. Relative bioavailability of rectally administered carbamazepine suspension in humans. Epilepsia. 1985;26:429–433.
  • Carnexiv [package insert]. Lundbeck; 2016.
  • Löscher W, Hönack D, Richter A, et al. New injectable aqueous carbamazepine solution through complexing with 2-hydroxypropyl-beta-cyclodextrin: tolerability and pharmacokinetics after intravenous injection in comparison to a glycofurol-based formulation. Epilepsia. 1995;36:255–261.
  • Ivaturi V, Cloyd J. Novel mechanisms of drug delivery. In: Rho J, Sankar R, Stafstr CE, editors. Epilepsy: mechanisms, models, and translational perspectives. Boca Raton (FL): CRC Press; 2010.
  • Nexterone [package insert]. Deerfield (IL): Baxter Healthcare Corporation; 2011.
  • ABILIFY [package insert]. Tokyo (Japan): Otsuka Pharmaceutical; 2014.
  • Kyprolis [package insert]. South San Francisco (CA): Onyx Pharmaceuticals; 2012.
  • VFEND [package insert]. New York (NY): Pfizer; 2014.
  • GEODON [package insert]. New York (NY): Pfizer; 2014.
  • Abel S, Allan R, Gandelman K, et al. Pharmacokinetics, safety and tolerance of voriconazole in renally impaired subjects: two prospective, multicentre, open-label, parallel-group volunteer studies. Clin Drug Investig. 2008;28:409–420.
  • Tomson T, Johannessen SI. Carbamazepine. In: Shorvon S, Perucca E, Engel J, editors. The treatment of epilepsy. 4th ed. John Wiley & Sons, Chichester, West Sussex, UK; 2016.
  • Vickery PB, Tillery EE, DeFalco AP. Intravenous carbamazepine for adults with seizures. Ann Pharmacother. 2018;52:285–289.
  • Tolbert D, Cloyd J, Biton V, et al. Bioequivalence of oral and intravenous carbamazepine formulations in adult patients with epilepsy. Epilepsia. 2015;56:915–923.
  • Jain AS, Date AA, Pissurlenkar RR, et al. Sulfobutyl ether(7) β-cyclodextrin (SBE(7) β-CD) carbamazepine complex: preparation, characterization, molecular modeling, and evaluation of in vivo anti-epileptic activity. AAPS Pharm Sci Tech. 2011;12:1163–1175.
  • Lee D, Kalu U, Halford JJ, et al. Intravenous carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: pooled tolerability results from two open-label trials. Epilepsia. 2015;56:906–914.
  • Dheerendra S, Klein P, Biton V, et al. IV carbamazepine as short-term replacement therapy for oral carbamazepine in adults with epilepsy: primary results of a phase III safety trial. Epilepsy Curr. 2014;14(Suppl.1):Abstract#3.301.
  • Liangos O, Perianayagam MC, Vaidya VS, et al. Urinary N-acetyl-beta-(D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol. 2007;18:904–912.
  • Patel SI, Birnbaum AK, Cloyd JC, et al. Intravenous and intramuscular formulations of antiseizure drugs in the treatment of epilepsy. CNS Drugs. 2015;29:1009–1022.
  • Ambrosi M, Orsini A, Verrotti A, et al. Medical management for neurosurgical related seizures. Expert Opin Pharmacother. 2017;18:1491–1498.
  • Leppik IE, Patel SI. Intramuscular and rectal therapies of acute seizures. Epilepsy Behav. 2015;49:307–312.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.